Table 1.

The top-cited studies on SARS-CoV-2 vaccines

	Title	Citation type	PMID	DOI	IF
1	Cryo-EM Structure of the 2019-nCoV Spike in the Perfusion Conformation	514Original	32075877	10.1126/science.abb2507	41.845
2	Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein	390Original	32155444	10.1016/j.cell.2020.02.058	38.637
3	Angiotensin-converting Enzyme 2 (ACE2) as a SARS-CoV-2 Receptor: Molecular Mechanisms and Potential Therapeutic TargetOpen Access	232Review	32125455	10.1007/s00134-020-05985-9	17.679
4	Drug Treatment Options for the 2019-New Coronavirus (2019-nCoV)Open Access	178Communication	31996494	10.5582/bst.2020.01020	1.690
5	Characterization of Spike Glycoprotein of SARS-CoV-2 on Virus Entry and Its Immune Cross-reactivity with SARS-CoV	138Original	32221306	10.1038/s41467-020-15562-9	12.121
6	Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) based on SARS-CoV Immunological StudiesOpen Access	114Original	32106567	10.3390/v12030254	3.816
7	Structure of Mpro from SARS-CoV-2 and Discovery of Its InhibitorsOpen Access	96Original	32272481	10.1038/s41586-020-2223-y	42.778
8	Characterization of the Receptor-binding Domain (RBD) of 2019 Novel Coronavirus: Implication for Development of RBD Protein as a Viral Attachment Inhibitor and Vaccine	80Original	32203189	10.1038/s41423-020-0400-4	8.484
9	A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug RepurposingOpen Access	78Original	32353859	10.1038/s41586-020-2286-9	42.778
10	Emergence of Genomic Diversity and Recurrent Mutations in SARS-CoV-2	77Review	32387564	10.1016/j.meegid.2020.104351	2.611

PMID; PubMed ID, DOI; Digital object identifier, and IF; Impact factor 2019.